Literature DB >> 16690914

Simian varicella virus gene 28 and 29 promoters share a common upstream stimulatory factor-binding site and are induced by IE62 transactivation.

Yang Ou1, Wayne L Gray.   

Abstract

Simian varicella virus (SVV) is a neurotropic alphaherpesvirus that causes a natural, varicella-like disease in non-human primates. After resolution of the primary disease, SVV, like its human counterpart, varicella-zoster virus (VZV), establishes latent infection in the neural ganglia of the host. In this study, gene expression of SVV open reading frames (ORFs) 28 and 29, which encode the viral DNA polymerase and DNA-binding protein, respectively, was characterized during lytic infection of Vero cells. The results indicate that the intergenic region controlling gene 28 and 29 expression includes overlapping, divergent promoters. The ORF 28 and 29 promoters are active in SVV-infected Vero cells, but not in uninfected cells. The SVV immediate-early gene 62 (IE62) product transactivates ORF 28 and 29 expression, and a cellular upstream stimulatory factor-binding site is important for efficient IE62 induction of genes 28 and 29. DNA sequence analysis of the 185 bp intergenic region identified putative cellular transcription factor-binding sites. Transcriptional analysis mapped ORF 28 and 29 RNA start sites. A recombinant SVV was employed to demonstrate that the ORF 29 promoter can express a heterologous gene (green fluorescent protein) when inserted into a novel site (the ORF 12/13 intergenic region) within the SVV genome. The findings demonstrate similarities between SVV and VZV ORF 28/29 expression and indicate that the simian varicella model may be useful to investigate the differential regulation of viral genes during lytic and latent infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690914     DOI: 10.1099/vir.0.81645-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Cloning the simian varicella virus genome in E. coli as an infectious bacterial artificial chromosome.

Authors:  Wayne L Gray; Fuchun Zhou; Juliane Noffke; B Karsten Tischer
Journal:  Arch Virol       Date:  2011-04-13       Impact factor: 2.574

Review 2.  Simian varicella virus: molecular virology.

Authors:  Wayne L Gray
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Recombinant simian varicella viruses induce immune responses to simian immunodeficiency virus (SIV) antigens in immunized vervet monkeys.

Authors:  Yang Ou; Vicki Traina-Dorge; Kara A Davis; Wayne L Gray
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

4.  The simian varicella virus ORF A is expressed in infected cells but is non-essential for replication in cell culture.

Authors:  Wayne L Gray
Journal:  Arch Virol       Date:  2012-06-08       Impact factor: 2.574

5.  Simian Varicella Virus: Molecular Virology and Mechanisms of Pathogenesis.

Authors:  Allen Jankeel; Izabela Coimbra-Ibraim; Ilhem Messaoudi
Journal:  Curr Top Microbiol Immunol       Date:  2021-10-21       Impact factor: 4.737

Review 6.  Comparative Analysis of the Simian Varicella Virus and Varicella Zoster Virus Genomes.

Authors:  Wayne L Gray
Journal:  Viruses       Date:  2022-04-19       Impact factor: 5.818

7.  Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.

Authors:  Barbara Berarducci; Marvin Sommer; Leigh Zerboni; Jaya Rajamani; Ann M Arvin
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

Review 8.  Current In Vivo Models of Varicella-Zoster Virus Neurotropism.

Authors:  Ravi Mahalingam; Anne Gershon; Michael Gershon; Jeffrey I Cohen; Ann Arvin; Leigh Zerboni; Hua Zhu; Wayne Gray; Ilhem Messaoudi; Vicki Traina-Dorge
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

9.  The architecture of the simian varicella virus transcriptome.

Authors:  Shirley E Braspenning; Georges M G M Verjans; Tamana Mehraban; Ilhem Messaoudi; Daniel P Depledge; Werner J D Ouwendijk
Journal:  PLoS Pathog       Date:  2021-11-22       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.